{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33747345", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "19"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "05"}], "Language": ["eng"], "ELocationID": ["4572471", "10.1155/2021/4572471"], "Journal": {"ISSN": "1942-0994", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Oxidative medicine and cellular longevity", "ISOAbbreviation": "Oxid Med Cell Longev"}, "ArticleTitle": "Dissecting Sex-Related Cognition between Alzheimer's Disease and Diabetes: From Molecular Mechanisms to Potential Therapeutic Strategies.", "Pagination": {"StartPage": "4572471", "MedlinePgn": "4572471"}, "Abstract": {"AbstractText": ["The brain is a sexually dimorphic organ that implies different functions and structures depending on sex. Current pharmacological approaches against different neurological diseases act distinctly in male and female brains. In all neurodegenerative diseases, including Alzheimer's disease (AD), sex-related outcomes regarding pathogenesis, prevalence, and response to treatments indicate that sex differences are important for precise diagnosis and therapeutic strategy. Pathogenesis of AD includes vascular dementia, and in most cases, this is accompanied by metabolic complications with similar features as those assembled in diabetes. This review discusses how AD-associated dementia and diabetes affect cognition in relation to sex difference, as both diseases share similar pathological mechanisms. We highlight potential protective strategies to mitigate amyloid-beta (A<i>\u03b2</i>) pathogenesis, emphasizing how these drugs act in the male and female brains."], "CopyrightInformation": "Copyright \u00a9 2021 Ghulam Md Ashraf et al."}, "AuthorList": [{"Identifier": ["0000-0002-9820-2078"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia."}], "LastName": "Ashraf", "ForeName": "Ghulam Md", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine, Zagazig University, Zagazig, El-Sharkia, Egypt."}, {"Identifier": [], "Affiliation": "National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt."}], "LastName": "Ebada", "ForeName": "Mahmoud Ahmed", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "King Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia."}, {"Identifier": [], "Affiliation": "Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia."}], "LastName": "Suhail", "ForeName": "Mohd", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Sciences of Agriculture, Food, Natural Resources, and Engineering (DAFNE), University of Foggia, Via Napoli 25, 71122 Foggia, Italy."}], "LastName": "Ali", "ForeName": "Ashraf", "Initials": "A"}, {"Identifier": ["0000-0002-0805-7840"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Southeast University, Dhaka, Bangladesh."}, {"Identifier": [], "Affiliation": "Pharmakon Neuroscience Research Network, Dhaka, Bangladesh."}], "LastName": "Uddin", "ForeName": "Md Sahab", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Entomology, Rutgers University, New Brunswick, NJ 018901, USA."}, {"Identifier": [], "Affiliation": "Deanship of Scientific Research, King Abdulaziz University, Jeddah, Saudi Arabia."}], "LastName": "Bilgrami", "ForeName": "Anwar L", "Initials": "AL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Glocal School of Life Sciences, Glocal University, Saharanpur, India."}], "LastName": "Perveen", "ForeName": "Asma", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Glocal School of Life Sciences, Glocal University, Saharanpur, India."}, {"Identifier": [], "Affiliation": "Centre for Science and Society, IISER Bhopal, India."}, {"Identifier": [], "Affiliation": "Innovation and Incubation Centre for Entrepreneurship, IISER Bhopal, India."}], "LastName": "Husain", "ForeName": "Amjad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Child Health, University of Missouri, Columbia, MO 65201, USA."}], "LastName": "Tarique", "ForeName": "Mohd", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Glocal School of Pharmacy, Glocal University, Saharanpur, India."}], "LastName": "Hafeez", "ForeName": "Abdul", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Novel Global Community Educational Foundation, New South Wales, Australia."}, {"Identifier": [], "Affiliation": "AFNP Med Austria, Wien, Austria."}], "LastName": "Alexiou", "ForeName": "Athanasios", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Uttar Pradesh, India."}], "LastName": "Ahmad", "ForeName": "Ausaf", "Initials": "A"}, {"Identifier": ["0000-0001-7614-245X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Amity Institute of Biotechnology, Amity University Uttar Pradesh Lucknow Campus, Uttar Pradesh, India."}], "LastName": "Kumar", "ForeName": "Rajnish", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physical Therapy, College of Medical Rehabilitation, Qassim University, Buraidah, Qassim, Saudi Arabia."}], "LastName": "Banu", "ForeName": "Naheed", "Initials": "N"}, {"Identifier": ["0000-0002-1185-8884"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Quality of Vegetables and Medicinal Plants, Department of Vegetable Crops and Medicinal Plants, University of Life Sciences in Lublin, 15 Akademicka Street, 20-950 Lublin, Poland."}], "LastName": "Najda", "ForeName": "Agnieszka", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Zoology Department, Faculty of Science, Cairo University, Giza 12613, Egypt."}], "LastName": "Sayed", "ForeName": "Amany A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh 11474, Saudi Arabia."}], "LastName": "Albadrani", "ForeName": "Ghadeer M", "Initials": "GM"}, {"Identifier": ["0000-0002-4341-2713"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacology Department, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt."}], "LastName": "Abdel-Daim", "ForeName": "Mohamed M", "Initials": "MM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Research Centre for Food and Nutrition, Council for Agricultural Research and Economics (CREA-AN), 00142 Rome, Italy."}], "LastName": "Peluso", "ForeName": "Ilaria", "Initials": "I"}, {"Identifier": ["0000-0002-6644-1971"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biological Sciences, University of Limerick, Limerick, Ireland."}, {"Identifier": [], "Affiliation": "Health Research Institute, University of Limerick, Limerick, Ireland."}], "LastName": "Barreto", "ForeName": "George E", "Initials": "GE"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oxid Med Cell Longev", "NlmUniqueID": "101479826", "ISSNLinking": "1942-0994"}, "MeshHeadingList": [{"QualifierName": ["genetics", "pathology", "physiopathology", "therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cognition"}, {"QualifierName": ["genetics", "pathology", "physiopathology", "therapy"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": [], "DescriptorName": "Risk Factors"}, {"QualifierName": [], "DescriptorName": "Sex Characteristics"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Alzheimer's Association, Thies W., Bleiler L. 2013 Alzheimer\u2019s disease facts and figures. Alzheimer's & Dementia. 2013;9(2):208\u2013245. doi: 10.1016/j.jalz.2013.02.003.", "ArticleIdList": ["10.1016/j.jalz.2013.02.003", "23507120"]}, {"Citation": "Uddin M. S., Tewari D., Mamun A. A., et al. Circadian and sleep dysfunction in Alzheimer's disease. Ageing Research Reviews. 2020;60, article 101046 doi: 10.1016/j.arr.2020.101046.", "ArticleIdList": ["10.1016/j.arr.2020.101046", "32171783"]}, {"Citation": "Santos C. Y., Snyder P. J., Wu W.-C., Zhang M., Echeverria A., Alber J. Pathophysiologic relationship between Alzheimer\u2019s disease, cerebrovascular disease, and cardiovascular risk: a review and synthesis. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2017;7(1):69\u201387. doi: 10.1016/j.dadm.2017.01.005.", "ArticleIdList": ["10.1016/j.dadm.2017.01.005", "PMC5328683", "28275702"]}, {"Citation": "Singh S. K., Srivastav S., Yadav A. K., Srikrishna S., Perry G. Overview of Alzheimer\u2019s disease and some therapeutic approaches targeting A\u03b2 by using several synthetic and herbal compounds. Oxidative Medicine and Cellular Longevity. 2016;2016:22. doi: 10.1155/2016/7361613.", "ArticleIdList": ["10.1155/2016/7361613", "PMC4807045", "27034741"]}, {"Citation": "Uddin M. S., Kabir M. T., Tewari D., et al. Revisiting the role of brain and peripheral A\u03b2 in the pathogenesis of Alzheimer's disease. Journal of the Neurological Sciences. 2020;416, article 116974 doi: 10.1016/j.jns.2020.116974.", "ArticleIdList": ["10.1016/j.jns.2020.116974", "32559516"]}, {"Citation": "Armstrong R. A. A critical analysis of the \u201camyloid cascade hypothesis\u201d. Folia Neuropathologica. 2014;52(3):211\u2013225.", "ArticleIdList": ["25310732"]}, {"Citation": "Fern\u00e1ndez-Botr\u00e1n R., Ahmed Z., Crespo F. A., et al. Cytokine expression and microglial activation in progressive supranuclear palsy. Parkinsonism & Related Disorders. 2011;17(9):683\u2013688. doi: 10.1016/j.parkreldis.2011.06.007.", "ArticleIdList": ["10.1016/j.parkreldis.2011.06.007", "PMC3196843", "21741294"]}, {"Citation": "Tarawneh R., Holtzman D. M. The clinical problem of symptomatic alzheimer disease and mild cognitive impairment. Cold Spring Harbor Perspectives in Medicine. 2012;2(5) doi: 10.1101/cshperspect.a006148.", "ArticleIdList": ["10.1101/cshperspect.a006148", "PMC3331682", "22553492"]}, {"Citation": "Perrotta M., Lembo G., Carnevale D. Hypertension and dementia: epidemiological and experimental evidence revealing a detrimental relationship. International Journal of Molecular Sciences. 2016;17(3):p. 347. doi: 10.3390/ijms17030347.", "ArticleIdList": ["10.3390/ijms17030347", "PMC4813208", "27005613"]}, {"Citation": "Rius-P\u00e9rez S., Tormos A. M., P\u00e9rez S., Tal\u00e9ns-Visconti R. Patologia vascular: \u00bfcausa o efecto en la enfermedad de Alzheimer? Neurolog\u00eda (English Edition) 2018;33(2):112\u2013120. doi: 10.1016/j.nrleng.2015.07.008.", "ArticleIdList": ["10.1016/j.nrleng.2015.07.008", "26385017"]}, {"Citation": "Zenaro E., Piacentino G., Constantin G. The blood-brain barrier in Alzheimer's disease. Neurobiology of Disease. 2017;107:41\u201356. doi: 10.1016/j.nbd.2016.07.007.", "ArticleIdList": ["10.1016/j.nbd.2016.07.007", "PMC5600438", "27425887"]}, {"Citation": "Seals D. R., Jablonski K. L., Donato A. J. Aging and vascular endothelial function in humans. Clinical Science. 2011;120(9):357\u2013375. doi: 10.1042/CS20100476.", "ArticleIdList": ["10.1042/CS20100476", "PMC3482987", "21244363"]}, {"Citation": "Iadecola C. The pathobiology of vascular dementia. Neuron. 2013;80(4):844\u2013866. doi: 10.1016/j.neuron.2013.10.008.", "ArticleIdList": ["10.1016/j.neuron.2013.10.008", "PMC3842016", "24267647"]}, {"Citation": "Dai M. H., Zheng H., Zeng L. D., Zhang Y. The genes associated with early-onset Alzheimer\u2019s disease. Oncotarget. 2018;9(19):15132\u201315143. doi: 10.18632/oncotarget.23738.", "ArticleIdList": ["10.18632/oncotarget.23738", "PMC5871104", "29599933"]}, {"Citation": "Reitz C., Mayeux R. Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers. Biochemical Pharmacology. 2014;88(4):640\u2013651. doi: 10.1016/j.bcp.2013.12.024.", "ArticleIdList": ["10.1016/j.bcp.2013.12.024", "PMC3992261", "24398425"]}, {"Citation": "Mamun A. A., Uddin M. S., Bin Bashar M. F., et al. Molecular insight into the therapeutic promise of targeting APOE4 for Alzheimer\u2019s disease. Oxidative Medicine and Cellular Longevity. 2020;2020:16. doi: 10.1155/2020/5086250.5086250", "ArticleIdList": ["10.1155/2020/5086250", "PMC7245681", "32509144"]}, {"Citation": "Zusso M., Barbierato M., Facci L., Skaper S. D., Giusti P. Neuroepigenetics and Alzheimer\u2019s disease: an update. Journal of Alzheimer's Disease. 2018;64(3):671\u2013688. doi: 10.3233/JAD-180259.", "ArticleIdList": ["10.3233/JAD-180259", "29991138"]}, {"Citation": "Rana M., Sharma A. K. Cu and Zn interactions with A\u03b2 peptides: consequence of coordination on aggregation and formation of neurotoxic soluble A\u03b2 oligomers. Metallomics. 2019;11(1):64\u201384. doi: 10.1039/C8MT00203G.", "ArticleIdList": ["10.1039/C8MT00203G", "30234208"]}, {"Citation": "Wang L., Yin Y. L., Liu X. Z., et al. Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Translational Neurodegeneration. 2020;9(1):p. 10. doi: 10.1186/s40035-020-00189-z.", "ArticleIdList": ["10.1186/s40035-020-00189-z", "PMC7119290", "32266063"]}, {"Citation": "Wainaina M. N., Chen Z., Zhong C. Environmental factors in the development and progression of late-onset Alzheimer\u2019s disease. Neuroscience Bulletin. 2014;30(2):253\u2013270. doi: 10.1007/s12264-013-1425-9.", "ArticleIdList": ["10.1007/s12264-013-1425-9", "PMC5562669", "24664867"]}, {"Citation": "Ebada M. A., Fayed N., Fayed L., et al. Efficacy of alpha-lipoic acid in the management of diabetes mellitus: a systematic review and meta-analysis. Iranian jourNal of Pharmaceutical Research: IJPR. 2019;18(4):2144\u20132156. doi: 10.22037/ijpr.2019.1100842.", "ArticleIdList": ["10.22037/ijpr.2019.1100842", "PMC7059057", "32184879"]}, {"Citation": "Heukamp I., Then C., Lechner A., Seissler J. Update on type 1 diabetes. Der Internist. 2013;54(2):201\u2013216. doi: 10.1007/s00108-012-3174-7.", "ArticleIdList": ["10.1007/s00108-012-3174-7", "23247771"]}, {"Citation": "Molina M. N., Ferder L., Manucha W. Emerging role of nitric oxide and heat shock proteins in insulin resistance. Current Hypertension Reports. 2016;18(1):p. 1. doi: 10.1007/s11906-015-0615-4.", "ArticleIdList": ["10.1007/s11906-015-0615-4", "26694820"]}, {"Citation": "Li J. Q., Tan L., Wang H. F., et al. Risk factors for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease: a systematic review and meta-analysis of cohort studies. Journal of Neurology, Neurosurgery, and Psychiatry. 2016;87(5):476\u2013484. doi: 10.1136/jnnp-2014-310095.", "ArticleIdList": ["10.1136/jnnp-2014-310095", "26001840"]}, {"Citation": "Hughes T. M., Craft S. The role of insulin in the vascular contributions to age-related dementia. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2016;1862(5):983\u2013991. doi: 10.1016/j.bbadis.2015.11.013.", "ArticleIdList": ["10.1016/j.bbadis.2015.11.013", "26657615"]}, {"Citation": "Zhang J., Chen C., Hua S., et al. An updated meta-analysis of cohort studies: Diabetes and risk of Alzheimer's disease. Diabetes Research and Clinical Practice. 2017;124:41\u201347. doi: 10.1016/j.diabres.2016.10.024.", "ArticleIdList": ["10.1016/j.diabres.2016.10.024", "28088029"]}, {"Citation": "Umegaki H. Type 2 diabetes as a risk factor for cognitive impairment: current insights. Clinical Interventions in Aging. 2014;9:1011\u20131019. doi: 10.2147/CIA.S48926.", "ArticleIdList": ["10.2147/CIA.S48926", "PMC4085321", "25061284"]}, {"Citation": "Laws K. R., Irvine K., Gale T. M. Sex differences in cognitive impairment in Alzheimer\u2019s disease. World Journal of Psychiatry. 2016;6(1):54\u201365. doi: 10.5498/wjp.v6.i1.54.", "ArticleIdList": ["10.5498/wjp.v6.i1.54", "PMC4804268", "27014598"]}, {"Citation": "Prince M. J., Wu F., Guo Y., et al. The burden of disease in older people and implications for health policy and practice. Lancet. 2015;385(9967):549\u2013562. doi: 10.1016/S0140-6736(14)61347-7.", "ArticleIdList": ["10.1016/S0140-6736(14)61347-7", "25468153"]}, {"Citation": "Xu X., Hilal S., Collinson S. L., et al. Validation of the total cerebrovascular disease burden scale in a community sample. Journal of Alzheimer's Disease. 2016;52(3):1021\u20131028. doi: 10.3233/JAD-160139.", "ArticleIdList": ["10.3233/JAD-160139", "27079726"]}, {"Citation": "Satterthwaite T. D., Connolly J. J., Ruparel K., et al. The Philadelphia Neurodevelopmental Cohort: a publicly available resource for the study of normal and abnormal brain development in youth. NeuroImage. 2016;124(Part B):1115\u20131119. doi: 10.1016/j.neuroimage.2015.03.056.", "ArticleIdList": ["10.1016/j.neuroimage.2015.03.056", "PMC4591095", "25840117"]}, {"Citation": "Mielke M. M., Ferretti M. T., Iulita M. F., Hayden K., Khachaturian A. S. Sex and gender in Alzheimer\u2019s disease\u2014does it matter? Alzheimer\u2019s & Dementia. 2018;14(9):1101\u20131103. doi: 10.1016/j.jalz.2018.08.003.", "ArticleIdList": ["10.1016/j.jalz.2018.08.003", "30196887"]}, {"Citation": "Beam C. R., Kaneshiro C., Jang J. Y., Reynolds C. A., Pedersen N. L., Gatz M. Differences between women and men in incidence rates of dementia and Alzheimer\u2019s disease. Journal of Alzheimer's Disease. 2018;64(4):1077\u20131083. doi: 10.3233/JAD-180141.", "ArticleIdList": ["10.3233/JAD-180141", "PMC6226313", "30010124"]}, {"Citation": "Uddin M. S., Rahman M. M., Jakaria M., et al. Estrogen signaling in Alzheimer\u2019s disease: molecular insights and therapeutic targets for Alzheimer\u2019s dementia. Molecular Neurobiology. 2020;57(6):2654\u20132670. doi: 10.1007/s12035-020-01911-8.", "ArticleIdList": ["10.1007/s12035-020-01911-8", "32297302"]}, {"Citation": "Poly T. N., Islam M. M., Walther B. A., et al. Association between use of statin and risk of dementia: a meta-analysis of observational studies. Neuroepidemiology. 2020;54(3):214\u2013226. doi: 10.1159/000503105.", "ArticleIdList": ["10.1159/000503105", "31574510"]}, {"Citation": "Liu C. K., Lai C. L., Tai C. T., Lin R. T., Yen Y. Y., Howng S. L. Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Neurology. 1998;50(6):1572\u20131579. doi: 10.1212/WNL.50.6.1572.", "ArticleIdList": ["10.1212/WNL.50.6.1572", "9633696"]}, {"Citation": "Yoshitake T., Kiyohara Y., Kato I., et al. Incidence and risk factors of vascular dementia and Alzheimer\u2019s disease in a defined elderly Japanese population: the Hisayama Study. Neurology. 1995;45(6):1161\u20131168. doi: 10.1212/WNL.45.6.1161.", "ArticleIdList": ["10.1212/WNL.45.6.1161", "7783883"]}, {"Citation": "Andersen K., Launer L. J., Dewey M. E., et al. Gender differences in the incidence of AD and vascular dementia: the EURODEM studies. Neurology. 1999;53(9):1992\u20131997. doi: 10.1212/WNL.53.9.1992.", "ArticleIdList": ["10.1212/WNL.53.9.1992", "10599770"]}, {"Citation": "Letenneur L., Gilleron V., Commenges D., Helmer C., Orgogozo J. M., Dartigues J. F. Are sex and educational level independent predictors of dementia and Alzheimer\u2019s disease? Incidence data from the PAQUID project. Journal of Neurology, Neurosurgery, and Psychiatry. 1999;66(2):177\u2013183. doi: 10.1136/jnnp.66.2.177.", "ArticleIdList": ["10.1136/jnnp.66.2.177", "PMC1736218", "10071096"]}, {"Citation": "Ott A., Breteler M. M., van Harskamp F., Stijnen T., Hofman A. Incidence and risk of dementia. The Rotterdam Study. American Journal of Epidemiology. 1998;147(6):574\u2013580. doi: 10.1093/oxfordjournals.aje.a009489.", "ArticleIdList": ["10.1093/oxfordjournals.aje.a009489", "9521184"]}, {"Citation": "Ruitenberg A., Ott A., van Swieten J. C., Hofman A., Breteler M. M. Incidence of dementia: does gender make a difference? Neurobiology of Aging. 2001;22(4):575\u2013580. doi: 10.1016/S0197-4580(01)00231-7.", "ArticleIdList": ["10.1016/S0197-4580(01)00231-7", "11445258"]}, {"Citation": "Bachman D. L., Wolf P. A., Linn R. T., et al. Incidence of dementia and probable Alzheimer\u2019s disease in a general population: the Framingham Study. Neurology. 1993;43, 3, Part 1:515\u2013519. doi: 10.1212/WNL.43.3_Part_1.515.", "ArticleIdList": ["10.1212/WNL.43.3_Part_1.515", "8450993"]}, {"Citation": "Edland S. D., Rocca W. A., Petersen R. C., Cha R. H., Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Archives of Neurology. 2002;59(10):1589\u20131593. doi: 10.1001/archneur.59.10.1589.", "ArticleIdList": ["10.1001/archneur.59.10.1589", "12374497"]}, {"Citation": "Ganguli M., Dodge H. H., Chen P., Belle S., DeKosky S. T. Ten-year incidence of dementia in a rural elderly US community population: the MoVIES Project. Neurology. 2000;54(5):1109\u20131116. doi: 10.1212/WNL.54.5.1109.", "ArticleIdList": ["10.1212/WNL.54.5.1109", "10720283"]}, {"Citation": "Hebert L. E., Scherr P. A., McCann J. J., Beckett L. A., Evans D. A. Is the risk of developing Alzheimer\u2019s disease greater for women than for men? American Journal of Epidemiology. 2001;153(2):132\u2013136. doi: 10.1093/aje/153.2.132.", "ArticleIdList": ["10.1093/aje/153.2.132", "11159157"]}, {"Citation": "Kawas C., Gray S., Brookmeyer R., Fozard J., Zonderman A. Age-specific incidence rates of Alzheimer\u2019s disease: the Baltimore Longitudinal Study of Aging. Neurology. 2000;54(11):2072\u20132077. doi: 10.1212/WNL.54.11.2072.", "ArticleIdList": ["10.1212/WNL.54.11.2072", "10851365"]}, {"Citation": "Rocca W. A., Cha R. H., Waring S. C., Kokmen E. Incidence of dementia and Alzheimer\u2019s disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. American Journal of Epidemiology. 1998;148(1):51\u201362. doi: 10.1093/oxfordjournals.aje.a009560.", "ArticleIdList": ["10.1093/oxfordjournals.aje.a009560", "9663404"]}, {"Citation": "Fratiglioni L., Viitanen M., von Strauss E., Tontodonati V., Herlitz A., Winblad B. Very old women at highest risk of dementia and Alzheimer\u2019s disease: incidence data from the Kungsholmen Project, Stockholm. Neurology. 1997;48(1):132\u2013138. doi: 10.1212/WNL.48.1.132.", "ArticleIdList": ["10.1212/WNL.48.1.132", "9008508"]}, {"Citation": "Roberts R. O., Knopman D. S., Mielke M. M., et al. Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology. 2014;82(4):317\u2013325. doi: 10.1212/WNL.0000000000000055.", "ArticleIdList": ["10.1212/WNL.0000000000000055", "PMC3929198", "24353333"]}, {"Citation": "Cognitive Function and Ageing Studies (CFAS) Collaboration, Matthews F. E., Stephan B. C. M., et al. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nature Communications. 2016;7(1) doi: 10.1038/ncomms11398.", "ArticleIdList": ["10.1038/ncomms11398", "PMC4838896", "27092707"]}, {"Citation": "Miech R. A., Breitner J. C. S., Zandi P. P., Khachaturian A. S., Anthony J. C., Mayer L. Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology. 2002;58(2):209\u2013218. doi: 10.1212/WNL.58.2.209.", "ArticleIdList": ["10.1212/WNL.58.2.209", "11805246"]}, {"Citation": "Chatterjee S., Peters S. A. E., Woodward M., et al. Type 2 diabetes as a risk factor for dementia in women compared with men: a pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care. 2016;39(2):300\u2013307. doi: 10.2337/dc15-1588.", "ArticleIdList": ["10.2337/dc15-1588", "PMC4722942", "26681727"]}, {"Citation": "Abdelnour C., van Steenoven I., Londos E., et al. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Movement Disorders. 2016;31(8):1203\u20131208. doi: 10.1002/mds.26668.", "ArticleIdList": ["10.1002/mds.26668", "27296778"]}, {"Citation": "White L. R., Edland S. D., Hemmy L. S., et al. Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies. Neurology. 2016;86(11):1000\u20131008. doi: 10.1212/WNL.0000000000002480.", "ArticleIdList": ["10.1212/WNL.0000000000002480", "PMC4799714", "26888993"]}, {"Citation": "for the Texas Alzheimer's Research and Care Consortium, Hall J. R., Wiechmann A. R., et al. Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer\u2019s disease. Journal of Alzheimer's Disease. 2013;35(2):363\u2013371. doi: 10.3233/JAD-122359.", "ArticleIdList": ["10.3233/JAD-122359", "PMC3631280", "23403534"]}, {"Citation": "Hanamsagar R., Bilbo S. D. Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development. The Journal of Steroid Biochemistry and Molecular Biology. 2016;160:127\u2013133. doi: 10.1016/j.jsbmb.2015.09.039.", "ArticleIdList": ["10.1016/j.jsbmb.2015.09.039", "PMC4829467", "26435451"]}, {"Citation": "Peterson B. L., Won S., Geddes R. I., Sayeed I., Stein D. G. Sex-related differences in effects of progesterone following neonatal hypoxic brain injury. Behavioural Brain Research. 2015;286:152\u2013165. doi: 10.1016/j.bbr.2015.03.005.", "ArticleIdList": ["10.1016/j.bbr.2015.03.005", "25746450"]}, {"Citation": "Furman D., Campisi J., Verdin E., et al. Chronic inflammation in the etiology of disease across the life span. Nature Medicine. 2019;25(12):1822\u20131832. doi: 10.1038/s41591-019-0675-0.", "ArticleIdList": ["10.1038/s41591-019-0675-0", "PMC7147972", "31806905"]}, {"Citation": "Xin J., Zhang Y., Tang Y., Yang Y. Brain differences between men and women: evidence from deep learning. Frontiers in Neuroscience. 2019;13:p. 185. doi: 10.3389/fnins.2019.00185.", "ArticleIdList": ["10.3389/fnins.2019.00185", "PMC6418873", "30906246"]}, {"Citation": "Altmann A., Tian L., Henderson V. W., Greicius M. D., Alzheimer's Disease Neuroimaging Initiative Investigators Sex modifies the APOE-related risk of developing Alzheimer disease. Annals of Neurology. 2014;75(4):563\u2013573. doi: 10.1002/ana.24135.", "ArticleIdList": ["10.1002/ana.24135", "PMC4117990", "24623176"]}, {"Citation": "Xing Y., Tang Y., Jia J. Sex differences in neuropsychiatric symptoms of Alzheimer\u2019s disease: the modifying effect of apolipoprotein E \u03b54 status. Behavioural Neurology. 2015;2015:6. doi: 10.1155/2015/275256.275256", "ArticleIdList": ["10.1155/2015/275256", "PMC4619911", "26538817"]}, {"Citation": "Butchart J., Birch B., Bassily R., Wolfe L., Holmes C. Male sex hormones and systemic inflammation in Alzheimer disease. Alzheimer Disease & Associated Disorders. 2013;27(2):153\u2013156. doi: 10.1097/WAD.0b013e318258cd63.", "ArticleIdList": ["10.1097/WAD.0b013e318258cd63", "22596080"]}, {"Citation": "Barron A. M., Pike C. J. Sex hormones, aging, and Alzheimer\u2019s disease. Frontiers in Bioscience (Elite edition) 2012;4:976\u2013997.", "ArticleIdList": ["PMC3511049", "22201929"]}, {"Citation": "Mikhael S., Punjala-Patel A., Gavrilova-Jordan L. Hypothalamic-pituitary-ovarian axis disorders impacting female fertility. Biomedicines. 2019;7(1):p. 5. doi: 10.3390/biomedicines7010005.", "ArticleIdList": ["10.3390/biomedicines7010005", "PMC6466056", "30621143"]}, {"Citation": "Crespo-Castrillo A., Yanguas-Casas N., Arevalo M. A., Azcoitia I., Barreto G. E., Garcia-Segura L. M. The synthetic steroid tibolone decreases reactive gliosis and neuronal death in the cerebral cortex of female mice after a stab wound injury. Molecular Neurobiology. 2018;55(11):8651\u20138667. doi: 10.1007/s12035-018-1008-x.", "ArticleIdList": ["10.1007/s12035-018-1008-x", "29582398"]}, {"Citation": "Hidalgo-Lanussa O., Avila-Rodriguez M., Baez-Jurado E., et al. Tibolone reduces oxidative damage and inflammation in microglia stimulated with palmitic acid through mechanisms involving estrogen receptor beta. Molecular Neurobiology. 2018;55(7):5462\u20135477. doi: 10.1007/s12035-017-0777-y.", "ArticleIdList": ["10.1007/s12035-017-0777-y", "28948468"]}, {"Citation": "Gonzalez-Giraldo Y., Garcia-Segura L. M., Echeverria V., Barreto G. E. Tibolone preserves mitochondrial functionality and cell morphology in astrocytic cells treated with palmitic acid. Molecular Neurobiology. 2018;55(5):4453\u20134462. doi: 10.1007/s12035-017-0667-3.", "ArticleIdList": ["10.1007/s12035-017-0667-3", "28667487"]}, {"Citation": "Acaz-Fonseca E., Avila-Rodriguez M., Garcia-Segura L. M., Barreto G. E. Regulation of astroglia by gonadal steroid hormones under physiological and pathological conditions. Progress in Neurobiology. 2016;144:5\u201326. doi: 10.1016/j.pneurobio.2016.06.002.", "ArticleIdList": ["10.1016/j.pneurobio.2016.06.002", "27283249"]}, {"Citation": "Avila-Rodriguez M., Garcia-Segura L. M., Hidalgo-Lanussa O., Baez E., Gonzalez J., Barreto G. E. Tibolone protects astrocytic cells from glucose deprivation through a mechanism involving estrogen receptor beta and the upregulation of neuroglobin expression. Molecular Neurobiology. 2016;433:35\u201346. doi: 10.1016/j.mce.2016.05.024.", "ArticleIdList": ["10.1016/j.mce.2016.05.024", "27250720"]}, {"Citation": "Avila Rodriguez M., Garcia-Segura L. M., Cabezas R., et al. Tibolone protects T98G cells from glucose deprivation. The Journal of Steroid Biochemistry and Molecular Biology. 2014;144(Part B):294\u2013303. doi: 10.1016/j.jsbmb.2014.07.009.", "ArticleIdList": ["10.1016/j.jsbmb.2014.07.009", "25086299"]}, {"Citation": "Baez E., Echeverria V., Cabezas R., Avila-Rodriguez M., Garcia-Segura L. M., Barreto G. E. Protection by neuroglobin expression in brain pathologies. Frontiers in Neurology. 2016;7:p. 146. doi: 10.3389/fneur.2016.00146.", "ArticleIdList": ["10.3389/fneur.2016.00146", "PMC5018480", "27672379"]}, {"Citation": "Gonzalez-Giraldo Y., Forero D. A., Echeverria V., et al. Neuroprotective effects of the catalytic subunit of telomerase: a potential therapeutic target in the central nervous system. Ageing Research Reviews. 2016;28:37\u201345. doi: 10.1016/j.arr.2016.04.004.", "ArticleIdList": ["10.1016/j.arr.2016.04.004", "27095058"]}, {"Citation": "Barreto G. E., Santos-Galindo M., Garcia-Segura L. M. Selective estrogen receptor modulators regulate reactive microglia after penetrating brain injury. Frontiers in Aging Neuroscience. 2014;6:p. 132. doi: 10.3389/fnagi.2014.00132.", "ArticleIdList": ["10.3389/fnagi.2014.00132", "PMC4064706", "24999330"]}, {"Citation": "Barreto G., Veiga S., Azcoitia I., Garcia-Segura L. M., Garcia-Ovejero D. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. European Journal of Neuroscience. 2007;25(10):3039\u20133046. doi: 10.1111/j.1460-9568.2007.05563.x.", "ArticleIdList": ["10.1111/j.1460-9568.2007.05563.x", "17561817"]}, {"Citation": "Toro-Urrego N., Garcia-Segura L. M., Echeverria V., Barreto G. E. Testosterone protects mitochondrial function and regulates neuroglobin expression in astrocytic cells exposed to glucose deprivation. Frontiers in Aging Neuroscience. 2016;8 doi: 10.3389/fnagi.2016.00152.", "ArticleIdList": ["10.3389/fnagi.2016.00152", "PMC4921852", "27445795"]}, {"Citation": "Hara Y., Waters E. M., McEwen B. S., Morrison J. H. Estrogen effects on cognitive and synaptic health over the lifecourse. Physiological Reviews. 2015;95(3):785\u2013807. doi: 10.1152/physrev.00036.2014.", "ArticleIdList": ["10.1152/physrev.00036.2014", "PMC4491541", "26109339"]}, {"Citation": "Aenlle K. K., Kumar A., Cui L., Jackson T. C., Foster T. C. Estrogen effects on cognition and hippocampal transcription in middle-aged mice. Neurobiology of Aging. 2009;30(6):932\u2013945. doi: 10.1016/j.neurobiolaging.2007.09.004.", "ArticleIdList": ["10.1016/j.neurobiolaging.2007.09.004", "PMC2730158", "17950954"]}, {"Citation": "Feldman H. A., Longcope C., Derby C. A., et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. The Journal of Clinical Endocrinology & Metabolism. 2002;87(2):589\u2013598. doi: 10.1210/jcem.87.2.8201.", "ArticleIdList": ["10.1210/jcem.87.2.8201", "11836290"]}, {"Citation": "Han X., Aenlle K. K., Bean L. A., et al. Role of estrogen Receptor\u00a0and\u00a0in preserving hippocampal function during aging. Journal of Neuroscience. 2013;33(6):2671\u20132683. doi: 10.1523/JNEUROSCI.4937-12.2013.", "ArticleIdList": ["10.1523/JNEUROSCI.4937-12.2013", "PMC3692013", "23392694"]}, {"Citation": "Murphy D. D., Segal M. Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. The Journal of Neuroscience. 1996;16(13):4059\u20134068. doi: 10.1523/JNEUROSCI.16-13-04059.1996.", "ArticleIdList": ["10.1523/JNEUROSCI.16-13-04059.1996", "PMC6578996", "8753868"]}, {"Citation": "Rettberg J. R., Yao J., Brinton R. D. Estrogen: a master regulator of bioenergetic systems in the brain and body. Frontiers in Neuroendocrinology. 2014;35(1):8\u201330. doi: 10.1016/j.yfrne.2013.08.001.", "ArticleIdList": ["10.1016/j.yfrne.2013.08.001", "PMC4024050", "23994581"]}, {"Citation": "Fgaier H., Mustafa I. H., Awad A. A., Elkamel A. Modeling the Interaction between \u03b2-Amyloid Aggregates and Choline Acetyltransferase Activity and Its Relation with Cholinergic Dysfunction through Two-Enzyme/Two-Compartment Model. Computational and Mathematical Methods in Medicine. 2015;2015:20. doi: 10.1155/2015/923762.923762", "ArticleIdList": ["10.1155/2015/923762", "PMC4568057", "26413144"]}, {"Citation": "Farzi M. A., Sadigh-Eteghad S., Ebrahimi K., Talebi M. Exercise improves recognition memory and acetylcholinesterase activity in the beta amyloid-induced rat model of Alzheimer\u2019s disease. Annals of Neurosciences. 2019;25(3):121\u2013125. doi: 10.1159/000488580.", "ArticleIdList": ["10.1159/000488580", "PMC6388429", "30814820"]}, {"Citation": "Morrison J. H., Brinton R. D., Schmidt P. J., Gore A. C. Estrogen, menopause, and the aging brain: how basic neuroscience can inform hormone therapy in women. Journal of Neuroscience. 2006;26(41):10332\u201310348. doi: 10.1523/JNEUROSCI.3369-06.2006.", "ArticleIdList": ["10.1523/JNEUROSCI.3369-06.2006", "PMC6674699", "17035515"]}, {"Citation": "Rocca W. A., Grossardt B. R., Shuster L. T. Oophorectomy, estrogen, and dementia: a 2014 update. Molecular and Cellular Endocrinology. 2014;389(1-2):7\u201312. doi: 10.1016/j.mce.2014.01.020.", "ArticleIdList": ["10.1016/j.mce.2014.01.020", "PMC4040304", "24508665"]}, {"Citation": "Hebert L. E., Weuve J., Scherr P. A., Evans D. A. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology. 2013;80(19):1778\u20131783. doi: 10.1212/WNL.0b013e31828726f5.", "ArticleIdList": ["10.1212/WNL.0b013e31828726f5", "PMC3719424", "23390181"]}, {"Citation": "Rocca W. A., Bower J. H., Maraganore D. M., et al. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology. 2007;69(11):1074\u20131083. doi: 10.1212/01.wnl.0000276984.19542.e6.", "ArticleIdList": ["10.1212/01.wnl.0000276984.19542.e6", "17761551"]}, {"Citation": "Shumaker S. A., Legault C., Kuller L., et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women\u2019s Health Initiative Memory Study. JAMA. 2004;291(24):2947\u20132958. doi: 10.1001/jama.291.24.2947.", "ArticleIdList": ["10.1001/jama.291.24.2947", "15213206"]}, {"Citation": "Collaborative Group on Hormonal Factors in Breast Cancer. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence. The Lancet. 2019;394(10204):1159\u20131168. doi: 10.1016/S0140-6736(19)31709-X.", "ArticleIdList": ["10.1016/S0140-6736(19)31709-X", "PMC6891893", "31474332"]}, {"Citation": "Santoro N., Epperson C. N., Mathews S. B. Menopausal symptoms and their management. Endocrinology and Metabolism Clinics of North America. 2015;44(3):497\u2013515. doi: 10.1016/j.ecl.2015.05.001.", "ArticleIdList": ["10.1016/j.ecl.2015.05.001", "PMC4890704", "26316239"]}, {"Citation": "Henderson V. W., Benke K. S., Green R. C., Cupples L. A., Farrer L. A., MIRAGE Study Group Postmenopausal hormone therapy and Alzheimer\u2019s disease risk: interaction with age. Journal of Neurology, Neurosurgery, and Psychiatry. 2005;76(1):103\u2013105. doi: 10.1136/jnnp.2003.024927.", "ArticleIdList": ["10.1136/jnnp.2003.024927", "PMC1739309", "15608005"]}, {"Citation": "Zarate S., Stevnsner T., Gredilla R. Role of estrogen and other sex hormones in brain Aging. Neuroprotection and DNA Repair. Frontiers in Aging Neuroscience. 2017;9:p. 430. doi: 10.3389/fnagi.2017.00430.", "ArticleIdList": ["10.3389/fnagi.2017.00430", "PMC5743731", "29311911"]}, {"Citation": "Russu M. C., Antonescu A. C. Sex Hormones in Neurodegenerative Processes and Diseases. IntechOpen; 2018. New Insights for Hormone Therapy in Perimenopausal Women Neuroprotection."}, {"Citation": "Yan X., Hu Y., Wang B., Wang S., Zhang X. Metabolic dysregulation contributes to the progression of Alzheimer\u2019s disease. Frontiers in Neuroscience. 2020;14, article 530219 doi: 10.3389/fnins.2020.530219.", "ArticleIdList": ["10.3389/fnins.2020.530219", "PMC7674854", "33250703"]}, {"Citation": "Magistretti P. J., Allaman I. A cellular perspective on brain energy metabolism and functional imaging. Neuron. 2015;86(4):883\u2013901. doi: 10.1016/j.neuron.2015.03.035.", "ArticleIdList": ["10.1016/j.neuron.2015.03.035", "25996133"]}, {"Citation": "Chawla A., Chawla R., Jaggi S. Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian Journal of Endocrinology and Metabolism. 2016;20(4):546\u2013551. doi: 10.4103/2230-8210.183480.", "ArticleIdList": ["10.4103/2230-8210.183480", "PMC4911847", "27366724"]}, {"Citation": "Kautzky-Willer A., Harreiter J., Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocrine Reviews. 2016;37(3):278\u2013316. doi: 10.1210/er.2015-1137.", "ArticleIdList": ["10.1210/er.2015-1137", "PMC4890267", "27159875"]}, {"Citation": "Liu S., Mauvais-Jarvis F. Minireview: Estrogenic protection of beta-cell failure in metabolic diseases. Endocrinology. 2010;151(3):859\u2013864. doi: 10.1210/en.2009-1107.", "ArticleIdList": ["10.1210/en.2009-1107", "PMC2840685", "19966178"]}, {"Citation": "Eaton W. W., Rose N. R., Kalaydjian A., Pedersen M. G., Mortensen P. B. Epidemiology of autoimmune diseases in Denmark. Journal of Autoimmunity. 2007;29(1):1\u20139. doi: 10.1016/j.jaut.2007.05.002.", "ArticleIdList": ["10.1016/j.jaut.2007.05.002", "PMC2717015", "17582741"]}, {"Citation": "Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047\u20131053. doi: 10.2337/diacare.27.5.1047.", "ArticleIdList": ["10.2337/diacare.27.5.1047", "15111519"]}, {"Citation": "Szalat A., Raz I. Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women. Diabetes, Obesity and Metabolism. 2008;10(12):1135\u20131156. doi: 10.1111/j.1463-1326.2008.00896.x.", "ArticleIdList": ["10.1111/j.1463-1326.2008.00896.x", "18494812"]}, {"Citation": "Federation I. D. IDF Diabetes Atlas. Brussels: Deakin University; 2013."}, {"Citation": "Morita A., Ishigaki Y. Gender-difference in diabetes mellitus. Nihon Rinsho. Japanese Journal of Clinical Medicine. 2015;73(4):606\u2013610.", "ArticleIdList": ["25936148"]}, {"Citation": "Tobias M. Global control of diabetes: information for action. Lancet. 2011;378(9785):3\u20134. doi: 10.1016/S0140-6736(11)60604-1.", "ArticleIdList": ["10.1016/S0140-6736(11)60604-1", "21705073"]}, {"Citation": "Jurgen H., Kautzky-Willer A. Sex and Gender Differences in Prevention of Type 2 Diabetes. Frontiers in Endocrinology. 2018;9:p. 220. doi: 10.3389/fendo.2018.00220.", "ArticleIdList": ["10.3389/fendo.2018.00220", "PMC5945816", "29780358"]}, {"Citation": "Sattar N. Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Practice & Research Clinical Endocrinology & Metabolism. 2013;27(4):501\u2013507. doi: 10.1016/j.beem.2013.05.006.", "ArticleIdList": ["10.1016/j.beem.2013.05.006", "24054927"]}, {"Citation": "Beatrice A. M., Dutta D., Kumar M., et al. Testosterone levels and type 2 diabetes in men: current knowledge and clinical implications. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2014;7:481\u2013486. doi: 10.2147/DMSO.S50777.", "ArticleIdList": ["10.2147/DMSO.S50777", "PMC4208349", "25349479"]}, {"Citation": "Nilsson P. M., Theobald H., Journath G., Fritz T. Gender differences in risk factor control and treatment profile in diabetes: a study in 229 swedish primary health care centres. Scandinavian Journal of Primary Health Care. 2009;22(1):27\u201331. doi: 10.1080/02813430310003264.", "ArticleIdList": ["10.1080/02813430310003264", "15119517"]}, {"Citation": "de Ritter R., de Jong M., Vos R. C., et al. Sex differences in the risk of vascular disease associated with diabetes. Biology of sex Differences. 2020;11(1):p. 1. doi: 10.1186/s13293-019-0277-z.", "ArticleIdList": ["10.1186/s13293-019-0277-z", "PMC6942348", "31900228"]}, {"Citation": "Pound N., Sturrock N. D., Jeffcoate W. J. Age related changes in glycated haemoglobin in patients with insulin-dependent diabetes mellitus. Diabetic Medicine. 1996;13(6):510\u2013513. doi: 10.1002/(SICI)1096-9136(199606)13:6<510::AID-DIA122>3.0.CO;2-W.", "ArticleIdList": ["10.1002/(SICI)1096-9136(199606)13:6<510::AID-DIA122>3.0.CO;2-W", "8799652"]}, {"Citation": "Raum E., Kr\u00e4mer H. U., R\u00fcter G., et al. Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice. 2012;97(3):377\u2013384. doi: 10.1016/j.diabres.2012.05.026.", "ArticleIdList": ["10.1016/j.diabres.2012.05.026", "22763108"]}, {"Citation": "Yoshimura Y., Kamada C., Takahashi K., et al. Relations of nutritional intake to age, sex and body mass index in Japanese elderly patients with type 2 diabetes: the Japanese Elderly Diabetes Intervention Trial. Geriatrics & Gerontology International. 2012;12(Suppl 1):29\u201340. doi: 10.1111/j.1447-0594.2011.00810.x.", "ArticleIdList": ["10.1111/j.1447-0594.2011.00810.x", "22435938"]}, {"Citation": "Retnakaran R., Kramer C. K., Ye C., et al. Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy. Diabetes Care. 2015;38(5):844\u2013851. doi: 10.2337/dc14-2551.", "ArticleIdList": ["10.2337/dc14-2551", "25693837"]}, {"Citation": "Siddiqui M. A., Khan M. F., Carline T. E. Gender differences in living with diabetes mellitus. Materia SocioMedica. 2013;25(2):140\u2013142. doi: 10.5455/msm.2013.25.140-142.", "ArticleIdList": ["10.5455/msm.2013.25.140-142", "PMC3769156", "24082841"]}, {"Citation": "Haataja L., Gurlo T., Huang C. J., Butler P. C. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocrine Reviews. 2008;29(3):303\u2013316. doi: 10.1210/er.2007-0037.", "ArticleIdList": ["10.1210/er.2007-0037", "PMC2528855", "18314421"]}, {"Citation": "Chatterjee S., Mudher A. Alzheimer\u2019s disease and type 2 diabetes: a critical assessment of the shared pathological traits. Frontiers in Neuroscience. 2018;12:p. 383. doi: 10.3389/fnins.2018.00383.", "ArticleIdList": ["10.3389/fnins.2018.00383", "PMC6008657", "29950970"]}, {"Citation": "Nowotny K., Jung T., Hohn A., Weber D., Grune T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules. 2015;5(1):194\u2013222. doi: 10.3390/biom5010194.", "ArticleIdList": ["10.3390/biom5010194", "PMC4384119", "25786107"]}, {"Citation": "Schedin-Weiss S., Winblad B., Tjernberg L. O. The role of protein glycosylation in Alzheimer disease. The FEBS Journal. 2014;281(1):46\u201362. doi: 10.1111/febs.12590.", "ArticleIdList": ["10.1111/febs.12590", "24279329"]}, {"Citation": "De Felice F. G., Ferreira S. T. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease. Diabetes. 2014;63(7):2262\u20132272.", "ArticleIdList": ["24931033"]}, {"Citation": "Rehman K., Akash M. S. Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? Journal of Biomedical Science. 2016;23(1):p. 87. doi: 10.1186/s12929-016-0303-y.", "ArticleIdList": ["10.1186/s12929-016-0303-y", "PMC5135788", "27912756"]}, {"Citation": "Uddin M. S., Kabir M. T., Mamun A. A., et al. Pharmacological approaches to mitigate neuroinflammation in Alzheimer\u2019s disease. International Immunopharmacology. 2020;84:p. 106479. doi: 10.1016/j.intimp.2020.106479.", "ArticleIdList": ["10.1016/j.intimp.2020.106479", "32353686"]}, {"Citation": "Ormazabal V., Nair S., Elfeky O., Aguayo C., Salomon C., Zuniga F. A. Association between insulin resistance and the development of cardiovascular disease. Cardiovascular Diabetology. 2018;17(1):p. 122. doi: 10.1186/s12933-018-0762-4.", "ArticleIdList": ["10.1186/s12933-018-0762-4", "PMC6119242", "30170598"]}, {"Citation": "Engelhart M. J., Geerlings M. I., Meijer J., et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Archives of Neurology. 2004;61(5):668\u2013672.", "ArticleIdList": ["15148142"]}, {"Citation": "Schmidt R., Schmidt H., Curb J. D., Masaki K., White L. R., Launer L. J. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study. Annals of Neurology. 2002;52(2):168\u2013174. doi: 10.1002/ana.10265.", "ArticleIdList": ["10.1002/ana.10265", "12210786"]}, {"Citation": "Anthony J. C., Breitner J. C., Zandi P. P., et al. Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study. Neurology. 2000;54(11):2066\u20132071.", "ArticleIdList": ["10851364"]}, {"Citation": "Broe G. A., Grayson D. A., Creasey H. M., et al. Anti-inflammatory drugs protect against Alzheimer disease at low doses. Archives of Neurology. 2000;57(11):1586\u20131591.", "ArticleIdList": ["11074790"]}, {"Citation": "Omeragic A., Kara-Yacoubian N., Kelschenbach J., et al. Peroxisome proliferator-activated receptor-gamma agonists exhibit anti-inflammatory and antiviral effects in an EcoHIV mouse model. Scientific Reports. 2019;9(1):p. 9428.", "ArticleIdList": ["PMC6603270", "31263138"]}, {"Citation": "Burgos-Moron E., Abad-Jimenez Z., Maranon A. M., et al. Relationship between oxidative stress, ER stress, and inflammation in type 2 diabetes: the battle continues. Journal of Clinical Medicine. 2019;8(9)", "ArticleIdList": ["PMC6780404", "31487953"]}, {"Citation": "Schmeichel A. M., Schmelzer J. D., Low P. A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes. 2003;52(1):165\u2013171. doi: 10.2337/diabetes.52.1.165.", "ArticleIdList": ["10.2337/diabetes.52.1.165", "12502508"]}, {"Citation": "Pinti M. V., Fink G. K., Hathaway Q. A., Durr A. J., Kunovac A., Hollander J. M. Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis. American Journal of Physiology-Endocrinology and Metabolism. 2019;316(2):E268\u2013E285.", "ArticleIdList": ["PMC6397358", "30601700"]}, {"Citation": "Dunn J., Grider M. H. Physiology, Adenosine Triphosphate. Treasure Island (FL): StatPearls; 2020.", "ArticleIdList": ["31985968"]}, {"Citation": "Tonnies E., Trushina E. Oxidative stress, synaptic dysfunction, and Alzheimer\u2019s disease. Journal of Alzheimer's Disease. 2017;57(4):1105\u20131121.", "ArticleIdList": ["PMC5409043", "28059794"]}, {"Citation": "Sakasai-Sakai A., Takata T., Suzuki H., Maruyama I., Motomiya Y., Takeuchi M. Immunological evidence for in vivo production of novel advanced glycation end-products from 1,5-anhydro-D-fructose, a glycogen metabolite. Scientific Reports. 2019;9(1):p. 10194. doi: 10.1038/s41598-019-46333-2.", "ArticleIdList": ["10.1038/s41598-019-46333-2", "PMC6629992", "31308400"]}, {"Citation": "Sergi D., Boulestin H., Campbell F. M., Williams L. M. The role of dietary advanced glycation end products in metabolic dysfunction. Molecular Nutrition & Food Research. 2021;65(1, article e1900934) doi: 10.1002/mnfr.201900934.", "ArticleIdList": ["10.1002/mnfr.201900934", "32246887"]}, {"Citation": "Fishman S. L., Sonmez H., Basman C., Singh V., Poretsky L. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Molecular Medicine. 2018;24(1):p. 59.", "ArticleIdList": ["PMC6251169", "30470170"]}, {"Citation": "Fournet M., Bonte F., Desmouliere A. Glycation damage: a possible hub for major pathophysiological disorders and aging. Aging and Disease. 2018;9(5):880\u2013900.", "ArticleIdList": ["PMC6147582", "30271665"]}, {"Citation": "Butterfield D. A., Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease. Nature Reviews Neuroscience. 2019;20(3):148\u2013160.", "ArticleIdList": ["PMC9382875", "30737462"]}, {"Citation": "Gepstein V., Weiss R. Obesity as the main risk factor for metabolic syndrome in children. Frontiers in Endocrinology. 2019;10:p. 568.", "ArticleIdList": ["PMC6706788", "31474943"]}, {"Citation": "Uddin M. S., Rahman M. M., Sufian M. A., et al. Exploring the new horizon of AdipoQ in obesity-related Alzheimer\u2019s dementia. Frontiers in Physiology. 2021;11, article 567678 doi: 10.3389/fphys.2020.567678.", "ArticleIdList": ["10.3389/fphys.2020.567678", "PMC7873563", "33584324"]}, {"Citation": "Beydoun M. A., Lhotsky A., Wang Y., et al. Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer\u2019s disease. American Journal of Epidemiology. 2008;168(10):1179\u20131189.", "ArticleIdList": ["PMC2582058", "18835864"]}, {"Citation": "Kroner Z. The relationship between Alzheimer\u2019s disease and diabetes: type 3 diabetes? Alternative Medicine Review : a Journal of Clinical Therapeutic. 2009;14(4):373\u2013379.", "ArticleIdList": ["20030463"]}, {"Citation": "Kivipelto M., Ngandu T., Fratiglioni L., et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Archives of Neurology. 2005;62(10):1556\u20131560.", "ArticleIdList": ["16216938"]}, {"Citation": "Gustafson D., Rothenberg E., Blennow K., Steen B., Skoog I. An 18-year follow-up of overweight and risk of Alzheimer disease. Archives of Internal Medicine. 2003;163(13):1524\u20131528. doi: 10.1001/archinte.163.13.1524.", "ArticleIdList": ["10.1001/archinte.163.13.1524", "12860573"]}, {"Citation": "Razay G., Vreugdenhil A., Wilcock G. The metabolic syndrome and Alzheimer disease. Archives of Neurology. 2007;64(1):93\u201396.", "ArticleIdList": ["17210814"]}, {"Citation": "Han W., Li C. Linking type 2 diabetes and Alzheimer\u2019s disease. Proceedings of the National Academy of Sciences of the United States of America. 2010;107(15):6557\u20136558. doi: 10.1073/pnas.1002555107.", "ArticleIdList": ["10.1073/pnas.1002555107", "PMC2872466", "20385830"]}, {"Citation": "Frake R. A., Ricketts T., Menzies F. M., Rubinsztein D. C. Autophagy and neurodegeneration. The Journal of Clinical Investigation. 2015;125(1):65\u201374.", "ArticleIdList": ["PMC4382230", "25654552"]}, {"Citation": "Uddin M. S., Mamun A. A., Labu Z. K., Hidalgo-Lanussa O., Barreto G. E., Ashraf G. M. Autophagic dysfunction in Alzheimer\u2019s disease: cellular and molecular mechanistic approaches to halt Alzheimer\u2019s pathogenesis. Journal of Cellular Physiology. 2019;234:8094\u20138112. doi: 10.1002/jcp.27588.", "ArticleIdList": ["10.1002/jcp.27588", "30362531"]}, {"Citation": "Uddin M. S., Stachowiak A., Mamun A. A., et al. Autophagy and Alzheimer\u2019s disease: from molecular mechanisms to therapeutic implications. Frontiers in Aging Neuroscience. 2018;10:p. 04. doi: 10.3389/fnagi.2018.00004.", "ArticleIdList": ["10.3389/fnagi.2018.00004", "PMC5797541", "29441009"]}, {"Citation": "Misgeld T., Schwarz T. L. Mitostasis in neurons: maintaining mitochondria in an extended cellular architecture. Neuron. 2017;96(3):651\u2013666.", "ArticleIdList": ["PMC5687842", "29096078"]}, {"Citation": "Masini M., Bugliani M., Lupi R., et al. Autophagy in human type 2 diabetes pancreatic beta cells. Diabetologia. 2009;52(6):1083\u20131086.", "ArticleIdList": ["19367387"]}, {"Citation": "Blagosklonny M. V. TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists. Cell Death & Disease. 2013;4, article e964", "ArticleIdList": ["PMC3877573", "24336084"]}, {"Citation": "de la Monte S. M. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer\u2019s disease. Drugs. 2012;72(1):49\u201366.", "ArticleIdList": ["PMC4550303", "22191795"]}, {"Citation": "Mullins R. J., Diehl T. C., Chia C. W., Kapogiannis D. Insulin resistance as a link between amyloid-beta and tau pathologies in Alzheimer\u2019s disease. Frontiers in Aging Neuroscience. 2017;9:p. 118. doi: 10.3389/fnagi.2017.00118.", "ArticleIdList": ["10.3389/fnagi.2017.00118", "PMC5413582", "28515688"]}, {"Citation": "Steen E., Terry B. M., Rivera E. J., et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2014is this type 3 diabetes? Journal of Alzheimer's Disease. 2005;7(1):63\u201380.", "ArticleIdList": ["15750215"]}, {"Citation": "Son S. M., Cha M. Y., Choi H., et al. Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease. Autophagy. 2016;12(5):784\u2013800. doi: 10.1080/15548627.2016.1159375.", "ArticleIdList": ["10.1080/15548627.2016.1159375", "PMC4854558", "26963025"]}, {"Citation": "Ho L., Qin W., Pompl P. N., et al. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease. FASEB Journal : official publication of the Federation of American Societies for Experimental Biology. 2004;18(7):902\u2013904. doi: 10.1096/fj.03-0978fje.", "ArticleIdList": ["10.1096/fj.03-0978fje", "15033922"]}, {"Citation": "Macauley S. L., Stanley M., Caesar E. E., et al. Hyperglycemia modulates extracellular amyloid-\u03b2 concentrations and neuronal activity in vivo. The Journal of Clinical Investigation. 2015;125(6):2463\u20132467. doi: 10.1172/JCI79742.", "ArticleIdList": ["10.1172/JCI79742", "PMC4497756", "25938784"]}, {"Citation": "Nizari S., Carare R. O., Hawkes C. A. Increased A\u03b2 pathology in aged Tg2576 mice born to mothers fed a high fat diet. Scientific Reports. 2016;6(1, article 21981) doi: 10.1038/srep21981.", "ArticleIdList": ["10.1038/srep21981", "PMC4766411", "26911528"]}, {"Citation": "Luppi M., Hitrec T., Di Cristoforo A., et al. Phosphorylation and dephosphorylation of tau protein during synthetic torpor. Frontiers in Neuroanatomy. 2019;13:p. 57.", "ArticleIdList": ["PMC6563845", "31244617"]}, {"Citation": "Duda P., Akula S. M., Abrams S. L., et al. Targeting GSK3 and associated signaling pathways involved in cancer. Cells. 2020;9(5):p. 1110. doi: 10.3390/cells9051110.", "ArticleIdList": ["10.3390/cells9051110", "PMC7290852", "32365809"]}, {"Citation": "Kimura T., Sharma G., Ishiguro K., Hisanaga S. I. Phospho-tau bar code: analysis of phosphoisotypes of tau and its application to tauopathy. Frontiers in Neuroscience. 2018;12:p. 44.", "ArticleIdList": ["PMC5808175", "29467609"]}, {"Citation": "Gratuze M., Julien J., Petry F. R., Morin F., Planel E. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer\u2019s disease-like tau pathology. Scientific Reports. 2017;7, article 46359", "ArticleIdList": ["PMC5389355", "28402338"]}, {"Citation": "Jung H. J., Kim Y. J., Eggert S., Chung K. C., Choi K. S., Park S. A. Age-dependent increases in tau phosphorylation in the brains of type 2 diabetic rats correlate with a reduced expression of p62. Experimental Neurology. 2013;248:441\u2013450.", "ArticleIdList": ["23906983"]}, {"Citation": "Qu Z., Jiao Z., Sun X., Zhao Y., Ren J., Xu G. Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain. Brain Research. 2011;1383:300\u2013306. doi: 10.1016/j.brainres.2011.01.084.", "ArticleIdList": ["10.1016/j.brainres.2011.01.084", "21281610"]}, {"Citation": "Savu O., Bradescu O. M., Serafinceanu C., Iosif L., Tirgoviste C. I., Stoian I. Erythrocyte caspase-3 and antioxidant defense is activated in red blood cells and plasma of type 2 diabetes patients at first clinical onset. Redox Report : Communications in Free Radical Research. 2013;18(2):56\u201362. doi: 10.1179/1351000213Y.0000000040.", "ArticleIdList": ["10.1179/1351000213Y.0000000040", "PMC6837364", "23485037"]}, {"Citation": "Kim B., Backus C., Oh S., Feldman E. L. Hyperglycemia-induced tau cleavage in vitro and in vivo: a possible link between diabetes and Alzheimer\u2019s disease. Journal of Alzheimer's Disease. 2013;34(3):727\u2013739. doi: 10.3233/JAD-121669.", "ArticleIdList": ["10.3233/JAD-121669", "PMC5545747", "23254634"]}, {"Citation": "Zhang F., Zhong R.-J., Cheng C., Li S., Le W.-D. New therapeutics beyond amyloid-\u03b2 and tau for the treatment of Alzheimer\u2019s disease. Acta Pharmacologica Sinica. 2020 doi: 10.1038/s41401-020-00565-5.", "ArticleIdList": ["10.1038/s41401-020-00565-5", "PMC8379190", "33268824"]}, {"Citation": "Pais M., Martinez L., Ribeiro O., et al. Early diagnosis and treatment of Alzheimer\u2019s disease: new definitions and challenges. Brazilian Journal of Psychiatry. 2020;42(4):431\u2013441.", "ArticleIdList": ["PMC7430379", "31994640"]}, {"Citation": "Sanni O., Erukainure O. L., Islam M. S. Pathology. Academic Press; 2020. Dacryodes edulis: protective antioxidant effects on diabetes pathology; pp. 205\u2013212."}, {"Citation": "Korol S. V., Tafreshiha A., Bhandage A. K., Birnir B., Jin Z. Insulin enhances GABAA receptor-mediated inhibitory currents in rat central amygdala neurons. Neuroscience Letters. 2018;671:76\u201381.", "ArticleIdList": ["29447952"]}, {"Citation": "Perez-Lloret S., Barrantes F. J. Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson\u2019s disease. NPJ Parkinson's disease. 2016;2, article 16001", "ArticleIdList": ["PMC5516588", "28725692"]}, {"Citation": "Avgerinos K. I., Kalaitzidis G., Malli A., Kalaitzoglou D., Myserlis P. G., Lioutas V. A. Intranasal insulin in Alzheimer\u2019s dementia or mild cognitive impairment: a systematic review. Journal of Neurology. 2018;265(7):1497\u20131510.", "ArticleIdList": ["PMC6465964", "29392460"]}, {"Citation": "Reger M. A., Watson G. S., Green P. S., et al. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 2008;70(6):440\u2013448. doi: 10.1212/01.WNL.0000265401.62434.36.", "ArticleIdList": ["10.1212/01.WNL.0000265401.62434.36", "17942819"]}, {"Citation": "Reger M. A., Watson G. S., Green P. S., et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-\u03b2 in memory-impaired older adults. Journal of Alzheimer's Disease. 2008;13(3):323\u2013331.", "ArticleIdList": ["PMC2804944", "18430999"]}, {"Citation": "Zhou X., Zhang R., Zou Z., et al. Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat. British Journal of Pharmacology. 2019;176(3):478\u2013490. doi: 10.1111/bph.14553.", "ArticleIdList": ["10.1111/bph.14553", "PMC6329628", "30471094"]}, {"Citation": "Fukuen S., Iwaki M., Yasui A., Makishima M., Matsuda M., Shimomura I. Sulfonylurea Agents Exhibit Peroxisome Proliferator-activated Receptor \u03b3 Agonistic Activity\u2217. The Journal of Biological Chemistry. 2005;280(25):23653\u201323659. doi: 10.1074/jbc.M412113200.", "ArticleIdList": ["10.1074/jbc.M412113200", "15764598"]}, {"Citation": "Gim H. J., Choi Y. S., Li H., Kim Y. J., Ryu J. H., Jeon R. Identification of a novel PPAR-\u03b3 agonist through a scaffold tuning approach. International Journal of Molecular Sciences. 2018;19(10):p. 3032. doi: 10.3390/ijms19103032.", "ArticleIdList": ["10.3390/ijms19103032", "PMC6213020", "30287791"]}, {"Citation": "Ma X., Wang D., Zhao W., Xu L. Deciphering the roles of PPARgamma in adipocytes via dynamic change of transcription complex. Frontiers in Endocrinology. 2018;9:p. 473.", "ArticleIdList": ["PMC6110914", "30186237"]}, {"Citation": "Khan M. A., Alam Q., Haque A., et al. Current progress on peroxisome proliferator-activated receptor gamma agonist as an emerging therapeutic approach for the treatment of Alzheimer\u2019s disease: an update. Current Neuropharmacology. 2019;17(3):232\u2013246.", "ArticleIdList": ["PMC6425074", "30152284"]}, {"Citation": "Yerevanian A., Soukas A. A. Metformin: mechanisms in human obesity and weight loss. Current Obesity Reports. 2019;8(2):156\u2013164.", "ArticleIdList": ["PMC6520185", "30874963"]}, {"Citation": "Gupta A., Bisht B., Dey C. S. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes. Neuropharmacology. 2011;60(6):910\u2013920. doi: 10.1016/j.neuropharm.2011.01.033.", "ArticleIdList": ["10.1016/j.neuropharm.2011.01.033", "21277873"]}, {"Citation": "Zhao M., Li X. W., Chen Z., et al. Neuro-protective role of metformin in patients with acute stroke and type 2 diabetes mellitus via AMPK/mammalian target of rapamycin (mTOR) signaling pathway and oxidative stress. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 2019;25:2186\u20132194. doi: 10.12659/MSM.911250.", "ArticleIdList": ["10.12659/MSM.911250", "PMC6442495", "30905926"]}, {"Citation": "Campbell J. M., Stephenson M. D., de Courten B., Chapman I., Bellman S. M., Aromataris E. Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis. Journal of Alzheimer's Disease. 2018;65(4):1225\u20131236.", "ArticleIdList": ["PMC6218120", "30149446"]}, {"Citation": "Qiu W. Q., Zhu H. Amylin and its analogs: a friend or foe for the treatment of Alzheimer\u2019s disease? Frontiers in Aging Neuroscience. 2014;6:p. 186.", "ArticleIdList": ["PMC4114192", "25120481"]}, {"Citation": "Verdile G., Fuller S. J., Martins R. N. The role of type 2 diabetes in neurodegeneration. Neurobiology of Disease. 2015;84:22\u201338.", "ArticleIdList": ["25926349"]}, {"Citation": "Adler B. L., Yarchoan M., Hwang H. M., et al. Neuroprotective effects of the amylin analogue pramlintide on Alzheimer\u2019s disease pathogenesis and cognition. Neurobiology of Aging. 2014;35(4):793\u2013801.", "ArticleIdList": ["24239383"]}, {"Citation": "d'Angelo M., Castelli V., Catanesi M., et al. PPAR\u03b3 and cognitive performance. International Journal of Molecular Sciences. 2019;20(20)", "ArticleIdList": ["PMC6834178", "31614739"]}, {"Citation": "Govindarajulu M., Pinky P. D., Bloemer J., Ghanei N., Suppiramaniam V., Amin R. Signaling mechanisms of selective PPAR\u03b3 modulators in Alzheimer\u2019s disease. PPAR Research. 2018;2018 doi: 10.1155/2018/2010675.2010675", "ArticleIdList": ["10.1155/2018/2010675", "PMC6215547", "30420872"]}, {"Citation": "Eggleton J. S., Jialal I. Thiazolidinediones. Treasure Island (FL): StatPearls; 2020."}, {"Citation": "Maimaiti S., Frazier H. N., Anderson K. L., et al. Novel calcium-related targets of insulin in hippocampal neurons. Neuroscience. 2017;364:130\u2013142. doi: 10.1016/j.neuroscience.2017.09.019.", "ArticleIdList": ["10.1016/j.neuroscience.2017.09.019", "PMC5653445", "28939258"]}, {"Citation": "Riess M. L., Elorbany R., Weihrauch D., Stowe D. F., Camara A. K. S. PPAR\u03b3-Independent side effects of thiazolidinediones on mitochondrial redox state in rat isolated hearts. Cells. 2020;9(1):p. 252. doi: 10.3390/cells9010252.", "ArticleIdList": ["10.3390/cells9010252", "PMC7017211", "31968546"]}, {"Citation": "Al-Muzafar H. M., Amin K. A. Thiazolidinedione induces a therapeutic effect on hepatosteatosis by regulating stearoyl-CoA desaturase-1, lipase activity, leptin and resistin. Experimental and Therapeutic Medicine. 2018;16(4):2938\u20132948. doi: 10.3892/etm.2018.6563.", "ArticleIdList": ["10.3892/etm.2018.6563", "PMC6125847", "30214514"]}, {"Citation": "Yaribeygi H., Atkin S. L., Pirro M., Sahebkar A. A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetes. Journal of Cellular Physiology. 2018;234(6):8286\u20138294.", "ArticleIdList": ["30417367"]}, {"Citation": "Brothers H. M., Gosztyla M. L., Robinson S. R. The Physiological Roles of Amyloid-\u03b2 Peptide Hint at New Ways to Treat Alzheimer's Disease. Frontiers in Aging Neuroscience. 2018;10:p. 118. doi: 10.3389/fnagi.2018.00118.", "ArticleIdList": ["10.3389/fnagi.2018.00118", "PMC5996906", "29922148"]}, {"Citation": "Montero-Odasso M., Ismail Z., Livingston G. One third of dementia cases can be prevented within the next 25\u2009years by tackling risk factors. The case \u201cfor\u201d and \u201cagainst\u201d. Alzheimer\u2019s Research & Therapy. 2020;12(1):p. 81. doi: 10.1186/s13195-020-00646-x.", "ArticleIdList": ["10.1186/s13195-020-00646-x", "PMC7346354", "32641088"]}, {"Citation": "Kirpichnikov D., McFarlane S. I., Sowers J. R. Metformin: an update. Annals of Internal Medicine. 2002;137(1):25\u201333. doi: 10.7326/0003-4819-137-1-200207020-00009.", "ArticleIdList": ["10.7326/0003-4819-137-1-200207020-00009", "12093242"]}, {"Citation": "Viollet B., Guigas B., Sanz Garcia N., Leclerc J., Foretz M., Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clinical Science. 2012;122(6):253\u2013270.", "ArticleIdList": ["PMC3398862", "22117616"]}, {"Citation": "Tong J.-J., Chen G.-H. Fight against glucose rescues age-related cognitive decline. Neuroscience Communications. 2015;1 doi: 10.14800/nc.862.", "ArticleIdList": ["10.14800/nc.862"]}, {"Citation": "Tong J.-J., Chen G.-H., Wang F., et al. Chronic acarbose treatment alleviates age-related behavioral and biochemical changes in SAMP8 mice. Behavioural Brain Research. 2015;284:138\u2013152. doi: 10.1016/j.bbr.2015.01.052.", "ArticleIdList": ["10.1016/j.bbr.2015.01.052", "25698601"]}, {"Citation": "Karalliedde J., Buckingham R. E. Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies. Drug Saf. 2007;30(9):741\u2013753. doi: 10.2165/00002018-200730090-00002.", "ArticleIdList": ["10.2165/00002018-200730090-00002", "17722967"]}, {"Citation": "Derosa G. Pioglitazone is a valid alternative to rosiglitazone. American Journal of Cardiovascular Drugs. 2011;11(6):357\u2013362. doi: 10.2165/11595990-000000000-00000.", "ArticleIdList": ["10.2165/11595990-000000000-00000", "21950735"]}, {"Citation": "Benalla W., Bellahcen S., Bnouham M. Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors. Current Diabetes Reviews. 2010;6(4):247\u2013254. doi: 10.2174/157339910791658826.", "ArticleIdList": ["10.2174/157339910791658826", "20522017"]}, {"Citation": "Sawada T., Shiotani H., Terashita D., et al. Comparison of effects of \u03b1-glucosidase inhibitors and glinide drugs on endothelial dysfunction in diabetic patients with coronary artery disease. Circulation Journal. 2014;78(1):248\u2013255. doi: 10.1253/circj.cj-13-0918.", "ArticleIdList": ["10.1253/circj.cj-13-0918", "24225338"]}, {"Citation": "McTaggart J. S., Clark R. H., Ashcroft F. M. The role of the KATP channel in glucose homeostasis in health and disease: more than meets the islet. The Journal of Physiology. 2010;588(17):3201\u20133209. doi: 10.1113/jphysiol.2010.191767.", "ArticleIdList": ["10.1113/jphysiol.2010.191767", "PMC2976015", "20519313"]}, {"Citation": "Pearson E. R., Flechtner I., Nj\u00f8lstad P. R., et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. New England Journal of Medicine. 2006;355(5):467\u2013477. doi: 10.1056/NEJMoa061759.", "ArticleIdList": ["10.1056/NEJMoa061759", "16885550"]}, {"Citation": "Yan F.-F., Casey J., Shyng S.-L. Sulfonylureas Correct Trafficking Defects of Disease-causing ATP-sensitive Potassium Channels by Binding to the Channel Complex. The Journal of Biological Chemistry. 2006;281(44):33403\u201333413. doi: 10.1074/jbc.M605195200.", "ArticleIdList": ["10.1074/jbc.M605195200", "16956886"]}, {"Citation": "Sebasti\u00e3o I., Candeias E., Santos M. S., de Oliveira C. R., Moreira P. I., Duarte A. I. Insulin as a bridge between type 2 diabetes and Alzheimer disease\u2014how anti-diabetics could be a solution for dementia. Frontiers in Endocrinology. 2014;5:p. 110.", "ArticleIdList": ["PMC4086025", "25071725"]}, {"Citation": "Grunberger G. Novel therapies for the management of type 2 diabetes mellitus: part 1. pramlintide and bromocriptine-QR. Journal of Diabetes. 2013;5(2):110\u2013117. doi: 10.1111/1753-0407.12034.", "ArticleIdList": ["10.1111/1753-0407.12034", "23452312"]}, {"Citation": "Rudinsky A. J., Adin C. A., Borin-Crivellenti S., Rajala-Schultz P., Hall M. J., Gilor C. Pharmacology of the glucagon-like peptide-1 analog exenatide extended-release in healthy cats. Domestic Animal Endocrinology. 2015;51:78\u201385. doi: 10.1016/j.domaniend.2014.12.003.", "ArticleIdList": ["10.1016/j.domaniend.2014.12.003", "25594949"]}, {"Citation": "Buturovic B. A., Ristic L. B., Narancic A. M. Effects of teraphy with basal insulin analogues combined with GLP 1 analogues and metformin in the treatment of obese patients with poorly regulated postprandial glycemia. Medical Archives. 2014;68(5):313\u2013316. doi: 10.5455/medarh.2014.68.313-316.", "ArticleIdList": ["10.5455/medarh.2014.68.313-316", "PMC4269541", "25568561"]}, {"Citation": "McIntosh C. H. S., Demuth H.-U., Pospisilik J. A., Pederson R. Dipeptidyl peptidase IV inhibitors: how do they work as new antidiabetic agents? Regulatory Peptides. 2005;128(2):159\u2013165. doi: 10.1016/j.regpep.2004.06.001.", "ArticleIdList": ["10.1016/j.regpep.2004.06.001", "15780435"]}, {"Citation": "Matveyenko A. V., Dry S., Cox H. I., et al. Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metformin. Diabetes. 2009;58(7):1604\u20131615. doi: 10.2337/db09-0058.", "ArticleIdList": ["10.2337/db09-0058", "PMC2699878", "19403868"]}, {"Citation": "Behme M. T., Dupr\u00e9 J., McDonald T. J. Glucagon-like peptide 1 improved glycemic control in type 1 diabetes. BMC Endocrine Disorders. 2003;3(1):p. 3. doi: 10.1186/1472-6823-3-3.", "ArticleIdList": ["10.1186/1472-6823-3-3", "PMC154101", "12697069"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "5", "Day": "21"}, {"Year": "2021", "Month": "1", "Day": "31"}, {"Year": "2021", "Month": "2", "Day": "11"}, {"Year": "2021", "Month": "3", "Day": "22", "Hour": "8", "Minute": "13"}, {"Year": "2021", "Month": "3", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["33747345", "PMC7960032", "10.1155/2021/4572471"]}}], "PubmedBookArticle": []}